CD14 and metabolic disease: Upon binding to the complex of CD14 and toll-like receptor 4 at the surface of innate immune cells, LPS can trigger the secretion of proinflammatory cytokines, which eventually impairs insulin sensitivity and induces insulin resistance-related metabolic disorders [31].